Secondary Logo

Journal Logo

March 2021 - Volume 44 - Issue 3

  • David E. Wazer, MD
  • 0277-3732
  • 1537-453X
  • 12 issues per year
  • Oncology 210/230
  • 1.907

Current Issue Highlights


Head and Neck


Eribulin Mesylate for the Treatment of Metastatic Hormone-refractory and Triple-negative Breast Cancer: A Multi-institutional Real-world Report on Efficacy and Safety

Valerio, Maria R.; Arrivas Bajardi, Eugenia; Arcara, Carmelo C.; More

American Journal of Clinical Oncology. 44(3):105-108, March 2021.



Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO): A Meet-URO Group Real World Study (Meet-Uro 7)

Santini, Daniele; Stellato, Marco; De Giorgi, Ugo; More

American Journal of Clinical Oncology. 44(3):121-125, March 2021.

Soft Tissue